Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer

Romain Boidot, Michael G.B. Blum, Marie-Pierre Wissler, Céline Gottin, Jiri Ruzicka, Sandy Chevrier, Tiffany M. Delhomme, Jérome Audoux, Adrien Jeanniard, Pierre-Alexandre Just, Philipp Harter, Sandro Pignata, Antonio González-Martin, Christian Marth, Johanna Mäenpää, Nicoletta Colombo, Ignace Vergote, Keiichi Fujiwara, Nicolas Duforet-Frebourg, Denis Bertrand, Nicolas Philippe, Isabelle Ray-Coquard, Eric Pujade-Lauraine the PAOLA-1/ ENGOT-ov25 Study Group
doi: https://doi.org/10.1101/2023.12.07.23299362

Article Information

doi 
https://doi.org/10.1101/2023.12.07.23299362
History 
  • December 8, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Romain Boidot1,
  2. Michael G.B. Blum2,*,
  3. Marie-Pierre Wissler3,
  4. Céline Gottin2,
  5. Jiri Ruzicka2,
  6. Sandy Chevrier1,
  7. Tiffany M. Delhomme2,
  8. Jérome Audoux2,
  9. Adrien Jeanniard4,
  10. Pierre-Alexandre Just5,
  11. Philipp Harter6,
  12. Sandro Pignata7,
  13. Antonio González-Martin8,
  14. Christian Marth9,
  15. Johanna Mäenpää10,
  16. Nicoletta Colombo11,
  17. Ignace Vergote12,
  18. Keiichi Fujiwara13,
  19. Nicolas Duforet-Frebourg2,
  20. Denis Bertrand2,
  21. Nicolas Philippe2,
  22. Isabelle Ray-Coquard14,
  23. Eric Pujade-Lauraine15 and
  24. the PAOLA-1/ ENGOT-ov25 Study Group
  1. 1Unit of Molecular Biology, Department of Biology and Pathology of Tumors, Georges-François Leclerc Cancer Center – UNICANCER, Dijon, France
  2. 2SeqOne Genomics, Montpellier, France
  3. 3CYPATH, Villeurbanne, France
  4. 4Agilent Technologies France, Les Ulis, France
  5. 5APHM (Assistance Publique - Hôpitaux de Marseille), Service de Pathologie Hôpitaux et services de santé, Marseille, Provence-Alpes-Côte d’Azur, France
  6. 6Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany
  7. 7Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples
  8. 8Clinica Universidad de Navarra, Madrid. Spain – GEICO
  9. 9Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria
  10. 10Tampere University Hospital, Department of Obstetrics and Gynecology
  11. 11University of Milan-Bicocca and European Institute of Oncology IRCCS, Milan, Italy
  12. 12University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union
  13. 13Saitama Medical University International Medical Center, Saitama, Japan
  14. 14Centre Léon BERARD, and University Claude Bernard Lyon I, Lyon and Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO), Lyon, France
  15. 15Association de Recherche Cancers Gynécologiques (ARCAGY-GINECO), Paris, France, Paris, France
  1. ↵*Corresponding author, michael.blum{at}seqone.com
Back to top
Posted December 08, 2023.
Download PDF
Data/Code
Email
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer
Romain Boidot, Michael G.B. Blum, Marie-Pierre Wissler, Céline Gottin, Jiri Ruzicka, Sandy Chevrier, Tiffany M. Delhomme, Jérome Audoux, Adrien Jeanniard, Pierre-Alexandre Just, Philipp Harter, Sandro Pignata, Antonio González-Martin, Christian Marth, Johanna Mäenpää, Nicoletta Colombo, Ignace Vergote, Keiichi Fujiwara, Nicolas Duforet-Frebourg, Denis Bertrand, Nicolas Philippe, Isabelle Ray-Coquard, Eric Pujade-Lauraine
medRxiv 2023.12.07.23299362; doi: https://doi.org/10.1101/2023.12.07.23299362
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area